Cargando…

Local Chemotherapy as an Adjuvant Treatment in Unresectable Squamous Cell Carcinoma: What Do We Know So Far?

Background: Squamous cell carcinoma (SCC) is one of the most common cancers involving skin and oral mucosa. Although this condition’s gold-standard treatment is the surgical removal of the lesions, the physician must propose alternative treatments in some cases due to the patient’s ineligibility for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bennardo, Luigi, Bennardo, Francesco, Giudice, Amerigo, Passante, Maria, Dastoli, Stefano, Morrone, Pietro, Provenzano, Eugenio, Patruno, Cataldo, Nisticò, Steven Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293038/ https://www.ncbi.nlm.nih.gov/pubmed/34201867 http://dx.doi.org/10.3390/curroncol28040213

Ejemplares similares

Erythema Multiforme and COVID-19: What Do We Know?
por: Bennardo, Luigi, et al.
Publicado: (2021)

Colchicine in Managing Skin Conditions: A Systematic Review
por: Dastoli, Stefano, et al.
Publicado: (2022)

Post-Stroke Asymmetric Prurigo Nodularis Responding to Dupilumab Treatment: A Case Report
por: Sammarra, Ilaria, et al.
Publicado: (2022)

Erythema Migrans-like COVID Vaccine Arm: A Literature Review
por: Fasano, Gaia, et al.
Publicado: (2022)

Skin Manifestations after Ionizing Radiation Exposure: A Systematic Review
por: Bennardo, Luigi, et al.
Publicado: (2021)

Q-Switched 1064/532 nm Laser with Nanosecond Pulse in Tattoo Treatment: A Double-Center Retrospective Study
por: Cannarozzo, Giovanni, et al.
Publicado: (2021)

What we know so far
Publicado: (2021)

Nanosecond Q-Switched 1064/532 nm Laser to Treat Hyperpigmentations: A Double Center Retrospective Study
por: Nisticò, Steven Paul, et al.
Publicado: (2021)

The Skin in Celiac Disease Patients: The Other Side of the Coin
por: Abenavoli, Ludovico, et al.
Publicado: (2019)

FDA-Approved Monoclonal Antibodies for Unresectable Hepatocellular Carcinoma: What Do We Know So Far?
por: Psilopatis, Iason, et al.
Publicado: (2023)

Anabaenopeptins: What We Know So Far
por: Monteiro, Patrick Romano, et al.
Publicado: (2021)

Clinical Evaluation on the Performance and Safety of a Non-Ablative Fractional 1340 nm Laser for the Treatment of Stretch Marks in Adolescents and Young Adults: A Case Series
por: Viviano, Maria Teresa, et al.
Publicado: (2022)

New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws
por: Bennardo, Francesco, et al.
Publicado: (2020)

Autoimmune pancreatitis: What we know so far
por: Masood, Muaaz
Publicado: (2021)

Incremental Hemodialysis: What We Know so Far
por: Soi, Vivek, et al.
Publicado: (2022)

Monkeypox transmission—what we know so far
por: Venkatesan, Priya
Publicado: (2022)

Amyloidogenesis: What Do We Know So Far?
por: Alraawi, Zeina, et al.
Publicado: (2022)

Moebius Syndrome: What We Know So Far
por: Zaidi, Syed Muhammad Hussain, et al.
Publicado: (2023)

Topical 5% Imiquimod Sequential to Surgery for HPV-Related Squamous Cell Carcinoma of the Lip
por: Pentangelo, Giovanni, et al.
Publicado: (2021)

Erbium Laser for Skin Surgery: A Single-Center Twenty-Five Years’ Experience
por: Nisticò, Steven Paul, et al.
Publicado: (2021)

Spider bites of medical significance in the Mediterranean area: misdiagnosis, clinical features and management
por: Fusto, Gabriele, et al.
Publicado: (2020)

Ixekizumab May Improve Renal Function in Psoriasis
por: Amoruso, Giuseppe Fabrizio, et al.
Publicado: (2021)

The emotional attentional blink: what we know so far
por: McHugo, Maureen, et al.
Publicado: (2013)

Ketogenic Diet and Epilepsy: What We Know So Far
por: D’Andrea Meira, Isabella, et al.
Publicado: (2019)

Thunderstorm-triggered asthma: what we know so far
por: Harun, Nur-Shirin, et al.
Publicado: (2019)

Diet in the Treatment of Epilepsy: What We Know So Far
por: Verrotti, Alberto, et al.
Publicado: (2020)

Coronavirus advice for associates: what we know so far
por: Goldman, James
Publicado: (2020)

Smoking and COVID-19: What we know so far
por: Shastri, Madhur D., et al.
Publicado: (2021)

COVID-19 and cancer: what we know so far
por: Sidaway, Peter
Publicado: (2020)

Neuroproteomics in Epilepsy: What Do We Know so Far?
por: do Canto, Amanda M., et al.
Publicado: (2021)

Cholangiocarcinoma and liver transplantation: What we know so far?
por: Safarpour, Ali Reza, et al.
Publicado: (2021)

Carotid Artery Calcification: What We Know So Far
por: Ahmed, Madeeha, et al.
Publicado: (2021)

Update on omicron variant: What we know so far
por: Choudhary, Gajendra, et al.
Publicado: (2022)

COVID-19 and Myositis: What We Know So Far
por: Saud, Ahmad, et al.
Publicado: (2021)

Eosinophilic Esophagitis—What Do We Know So Far?
por: Wąsik, Jakub, et al.
Publicado: (2023)

HIV and neoplasms: What do we know so far?
por: de Souza, Thais Faria, et al.
Publicado: (2023)

Fibrocartilaginous dysplasia: What do we know so far?
por: Alshalan, Asma, et al.
Publicado: (2023)

Three-dimensional facial swelling evaluation of pre-operative single-dose of prednisone in third molar surgery: a split-mouth randomized controlled trial
por: Antonelli, Alessandro, et al.
Publicado: (2023)

Combination of Specific Vascular Lasers and Vascular Intense Pulsed Light Improves Facial Telangiectasias and Redness
por: Bennardo, Luigi, et al.
Publicado: (2022)

The effects of huntingtin-lowering: what do we know so far?
por: Kaemmerer, William F, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9mirbd2rtdj0n1cjkqp4ku8tpt